These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35862190)

  • 21. Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia.
    van Velzen M; Jing L; Osterhaus AD; Sette A; Koelle DM; Verjans GM
    PLoS Pathog; 2013 Aug; 9(8):e1003547. PubMed ID: 23966859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
    Posavad CM; Wald A; Hosken N; Huang ML; Koelle DM; Ashley RL; Corey L
    J Immunol; 2003 Apr; 170(8):4380-8. PubMed ID: 12682275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells.
    Hensel MT; Peng T; Cheng A; De Rosa SC; Wald A; Laing KJ; Jing L; Dong L; Magaret AS; Koelle DM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia.
    Tolba KA; Bowers WJ; Hilchey SP; Halterman MW; Howard DF; Giuliano RE; Federoff HJ; Rosenblatt JD
    Blood; 2001 Jul; 98(2):287-95. PubMed ID: 11435295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4
    Srivastava R; Coulon PA; Prakash S; Dhanushkodi NR; Roy S; Nguyen AM; Alomari NI; Mai UT; Amezquita C; Ye C; Maillère B; BenMohamed L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31915285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.
    Johnston C; Zhu J; Jing L; Laing KJ; McClurkan CM; Klock A; Diem K; Jin L; Stanaway J; Tronstein E; Kwok WW; Huang ML; Selke S; Fong Y; Magaret A; Koelle DM; Wald A; Corey L
    J Virol; 2014 May; 88(9):4921-31. PubMed ID: 24554666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes Simplex Virus Causing Necrotizing Granulomatous Lymphadenitis.
    Parmar V; Bayya M; Kak V
    Cureus; 2022 Mar; 14(3):e23709. PubMed ID: 35505723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.
    Tinhofer I; Marschitz I; Kos M; Henn T; Egle A; Villunger A; Greil R
    Blood; 1998 Jun; 91(11):4273-81. PubMed ID: 9596676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HSV lymphadenitis in chronic lymphocytic leukemia -- a rare but difficult differential diagnosis].
    Grözinger G; Adam P; Horger M
    Rofo; 2014 Jan; 186(1):79-80. PubMed ID: 23975876
    [No Abstract]   [Full Text] [Related]  

  • 30. Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restores the Function of Antiviral Tissue-Resident CD8
    Roy S; Coulon PG; Prakash S; Srivastava R; Geertsema R; Dhanushkodi N; Lam C; Nguyen V; Gorospe E; Nguyen AM; Salazar S; Alomari NI; Warsi WR; BenMohamed L
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31217250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice.
    Fernandez MA; Puttur FK; Wang YM; Howden W; Alexander SI; Jones CA
    J Immunol; 2008 Feb; 180(3):1556-64. PubMed ID: 18209051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homing in on the cellular immune response to HSV-2 in humans.
    Koelle DM; Gonzalez JC; Johnson AS
    Am J Reprod Immunol; 2005 Apr; 53(4):172-81. PubMed ID: 15760378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Ibrutinib Therapy Reverses CD8
    Parry HM; Mirajkar N; Cutmore N; Zuo J; Long H; Kwok M; Oldrieve C; Hudson C; Stankovic T; Paneesha S; Kelly M; Begum J; McSkeane T; Pratt G; Moss P
    Front Immunol; 2019; 10():2832. PubMed ID: 31921116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic changes in HLA-DR expression during short-term and long-term ibrutinib treatment in patients with chronic lymphocytic leukemia.
    Manukyan G; Turcsanyi P; Mikulkova Z; Gabcova G; Urbanova R; Gajdos P; Smotkova Kraiczova V; Zehnalova S; Papajik T; Kriegova E
    Leuk Res; 2018 Sep; 72():113-119. PubMed ID: 30149317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymptomatic HLA-A*02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes.
    Dervillez X; Qureshi H; Chentoufi AA; Khan AA; Kritzer E; Yu DC; Diaz OR; Gottimukkala C; Kalantari M; Villacres MC; Scarfone VM; McKinney DM; Sidney J; Sette A; Nesburn AB; Wechsler SL; BenMohamed L
    J Immunol; 2013 Nov; 191(10):5124-38. PubMed ID: 24101547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Herpes Simplex Virus 1 Glycoproteins Differentially Regulate the Activity of Costimulatory Molecules and T Cells.
    Matundan HH; Jaggi U; Ghiasi H
    mSphere; 2022 Oct; 7(5):e0038222. PubMed ID: 36094100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8
    Lopes PP; Todorov G; Pham TT; Nesburn AB; Bahraoui E; BenMohamed L
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic mice against ocular herpes.
    Srivastava R; Khan AA; Spencer D; Vahed H; Lopes PP; Thai NT; Wang C; Pham TT; Huang J; Scarfone VM; Nesburn AB; Wechsler SL; BenMohamed L
    J Immunol; 2015 Mar; 194(5):2232-48. PubMed ID: 25617474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus type 2 serostatus is not associated with inflammatory or metabolic markers in antiretroviral therapy-treated HIV.
    Tan DH; Raboud JM; Szadkowski L; Yi TJ; Shannon B; Kaul R; Liles WC; Walmsley SL
    AIDS Res Hum Retroviruses; 2015 Mar; 31(3):276-81. PubMed ID: 25399537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2.
    Long BR; Erickson AE; Chapman JM; Barbour JD; Vu BA; Ho EL; Lanier LL; Sauer MM; Carvalho KI; Nixon DF; Kallas EG
    Immunology; 2010 Feb; 129(2):186-96. PubMed ID: 19824915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.